期刊文献+

经皮冠状动脉介入治疗前应用不同剂量替罗非班对不同性别的急性ST段抬高型心肌梗死患者的临床疗效分析 被引量:4

Clinical analysis of different doses of tirofiban in male and female patients with ST-elevation myocardial infarction during primary percutaneous coronary intervention
下载PDF
导出
摘要 目的:探讨替罗非班对行经皮冠状动脉介入治疗(PCI)的急性 ST 段抬高型心肌梗死不同性别患者使用不同剂量的疗效差异,为临床选择最佳治疗剂量提供依据。方法将239例行 PCI 的 ST 段抬高型急性心肌梗死患者分为对照组和试验组,对照组未给予替罗非班,试验组于PCI 术前30分钟给予动脉注射替罗非班注射液。应用相关检查仪器观察各组 ST 段回落、校正TIMI帧数(CTFC)、左心室收缩末期内径(LVESD)、短轴收缩率(FS)、左心室射血分数(LVEF)等指标的变化情况,并用流式细胞仪检测 CD63、CD62p 的阳性表达率。结果术后的 ST 段回落、CTFC、LVESD、FS、LVEF、CD63、CD62p 等指标与术前同组相比,差异有统计学意义(P <0.05);试验组与同性别对照组比较,差异有统计学意义(P <0.05);半剂量男性试验组与标准剂量男性试验组术后 CD63、CD62p 比较,差异有统计学意义(P <0.05)。结论对于行 PCI 手术的心肌梗死患者,术前应用替罗非班能取得更好的效果,对于女性患者半剂量效果更佳。 Objective To explore the effect of different doses of tirofiban in female and male patients with ST-elevation myocardial infarction (STEMI ) undergoing primary percutaneous coronary intervention(PCI)and to provide the best dose for clinical management.Methods A total of 239 STEMI patients underwent primary PCI were enrolled in this study,according to gender and depending on whether the application of tirofiban,divided into experimental and control groups.The control group without tirofiban,the experimental group was given intra-arterial injection of tirofiban in preoperative 30 min. Application-related inspection equipment to observe the indicators of ST-segment elevation,corrected TIMI frame count (CTFC),left ventricular end systolic diameter(LVESD),fractional shortening (FS),left ventricularejection fraction (LVEF).The positive expression rate of CD63 and CD62p were measured by flow cytometry.Results Compare with the decline degree of ST segment,CTFC,LAVESD,FS,LVEF, CD63 and CD62p,there were significantly different before and after PCI (P 〈0.05 ).There were also significantly different between the experimental group and the same gender control group(P 〈0.05). Compared with the half dose male experimental group with standard dose male experimental group after CD63,CD62p,the differences were statistically significant (P 〈0.05 ).Conclusion For the STEMI patients underwent primary PCI,tirofiban can achieve better effect,while half dose of that was better for women.
出处 《临床内科杂志》 CAS 2015年第3期181-184,共4页 Journal of Clinical Internal Medicine
基金 河南省科学技术厅资助项目(9412013Y0252)
关键词 急性ST段抬高型心肌梗死/治疗 替罗非班 性别差异 ST-elevation myocardial infarction/Treatment Tirofiban Gender difference
  • 相关文献

参考文献12

  • 1Becker DM,Segal J,Vaidya D,et al.Sex differences in platelet reactivi- ty and response to low-dose aspirin therapy[J].JAMA,2006,295(12):1420-1427.
  • 2胡玉卿,赵洁,詹建刚,马先槎.用流式细胞术检测CD62P,CD63对预测血栓性疾病的临床意义[J].中国现代医学杂志,2003,13(2):92-93. 被引量:10
  • 3田锐,吕树铮,柳弘,陈新,刘欣,宋宪涛,朱华刚.盐酸替罗非班在急性心肌梗死患者介入治疗中的应用[J].新乡医学院学报,2012,29(2):129-130. 被引量:7
  • 4Hochman JS,Buller CE,Sleeper LA,et al.Cardiogenic shock complica- ting acute myocardial infarction etiologies,management and outcome:A report from the SHOCK Trial Registry[J].J Am Coll Cardiol,2001,36(3);1063-1070.
  • 5De Lemos JA,Braunwald E.ST segment resolution as a tool for assess- ing the efficacy of reperfusion therapy[J].J Am Coll Cardiol,2001,38(5):1283-1294.
  • 6尹作民,马海龙,刘为生,滕军.CTFC对STEMI急诊PCI术后心肌血流灌注的评价[J].齐鲁医学杂志,2005,20(4):283-285. 被引量:2
  • 7Michelson AD,Barmard MR,Krueger LA.Evaluation of plateletfunction by flow,cytometry[J].Methods,2000,21(3);259-270.
  • 8Schwartzenberg S,Halkin A,Finkelstein A,et al.The no-re-flow phe- nomenon following percutaneous coronary intervention[J].Harefuah,2009,148(6):381-385.
  • 9Niccoli G,Burzotta F,Galiuto L,et al.Myocardial no-reflow in humans[J].J Am Coll Cardiol,2009,54(4):281-292.
  • 10Wu TG,Zhao Q,Huang WG,et al.Effect of intracoronary tirom-ban in patients undergoing percutaneous coronary intervention foracute coro- nary syndrome[J].Circ J,2008,72(10):1605-1609.

二级参考文献30

  • 1[3]Dunlop cl skinner MP Bendall LJ, etalcharacteriration of GMP-140(P-Selectin)as a circulating plasma protein.J EXP Med,1992;175:1147
  • 2[5]Matsunok.Detetion of platelet activation.Rinsho Byori,1995;43:432
  • 3[6]Snattil SJ, Cunningham. M Hoxie TA,Detection of activated plateiets in whole blood using activation dependent monoclonal antibodies and flow cytometry .Blood,1987;70:307
  • 4[7]Metzelaar MJ,Sixma JJ,Nieuwenhuis HK .Detection of platetet activation using activation specific monoclonal antibodies.Blood cell,1990;16:85
  • 5Spoden G A, Mazurek S, Morandell D, et al. Isotype-specific inhibi- tors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation [ J]. Int J Cancer, 2008,123(2) :312-321.
  • 6Softer D, Moussa I, Karatepe M, et al. Suboptimal inhibition of platelet aggregation following tirofiban bolus in patients undergoing percutaneous coronary intervention for unstable angina pectoris [J]. Am J Cardiol,2003 ,91 (7) :872-875.
  • 7Razakjr O A,Tan H C ,Yip W L,et al. Predictors of bleeding com- plications and thrombocytopenia with the use of abciximab during percutaneous coronary intervention [ J ]. J Interv Cardiol , 2005,18( 1 ) :33-37.
  • 8Tungsubutra W,Tresukosol D, Krittayaphong R, et al. Primary per- cutaneous transluminal coronary intervention compared with intra- venous thrombolysis in patients with ST segment elevation myocar- dial infarction[J]. J Med Assoc Thai,2007,90(4) :672-678.
  • 9Elmouehi D A, Bates E R. Platelet glycoprotein IIb/IIIa inhibitor therapy in non-ST segment elevation acute coronary gyndromes [ J ]. Minerva Cardioangiol,2003,51 ( 5 ):547-560.
  • 10Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials[J]. Lancet,2003,361(9351): 13.

共引文献25

同被引文献39

引证文献4

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部